Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 ( STAT1 ) mutation by Higgins, Eleanor, MRCPI, Al Shehri, Tariq, MSc, McAleer, Maeve A., MRCPI, Conlon, Niall, PhD, FRCPath, Feighery, Conleth, MD, Lilic, Desa, MD, PhD, Irvine, Alan D., MD

Get full text